189 related articles for article (PubMed ID: 38659259)
1. Therapeutic Expedition of Luteolin against Brain-related Disorders: An Updated Review.
Singh NK; Bhushan B; Singh P; Sahu KK
Comb Chem High Throughput Screen; 2024 Apr; ():. PubMed ID: 38659259
[TBL] [Abstract][Full Text] [Related]
2. Luteolin as an anti-inflammatory and neuroprotective agent: A brief review.
Nabavi SF; Braidy N; Gortzi O; Sobarzo-Sanchez E; Daglia M; Skalicka-Woźniak K; Nabavi SM
Brain Res Bull; 2015 Oct; 119(Pt A):1-11. PubMed ID: 26361743
[TBL] [Abstract][Full Text] [Related]
3. Neuroprotective effects of flavone luteolin in neuroinflammation and neurotrauma.
Kempuraj D; Thangavel R; Kempuraj DD; Ahmed ME; Selvakumar GP; Raikwar SP; Zaheer SA; Iyer SS; Govindarajan R; Chandrasekaran PN; Zaheer A
Biofactors; 2021 Mar; 47(2):190-197. PubMed ID: 33098588
[TBL] [Abstract][Full Text] [Related]
4. Luteolin: Nature's promising warrior against Alzheimer's and Parkinson's disease.
Goyal A; Solanki K; Verma A
J Biochem Mol Toxicol; 2024 Jan; 38(1):e23619. PubMed ID: 38091364
[TBL] [Abstract][Full Text] [Related]
5. The Flavone Luteolin Improves Central Nervous System Disorders by Different Mechanisms: A Review.
Ashaari Z; Hadjzadeh MA; Hassanzadeh G; Alizamir T; Yousefi B; Keshavarzi Z; Mokhtari T
J Mol Neurosci; 2018 Aug; 65(4):491-506. PubMed ID: 30083786
[TBL] [Abstract][Full Text] [Related]
6. Naringenin: A prospective therapeutic agent for Alzheimer's and Parkinson's disease.
Goyal A; Verma A; Dubey N; Raghav J; Agrawal A
J Food Biochem; 2022 Dec; 46(12):e14415. PubMed ID: 36106706
[TBL] [Abstract][Full Text] [Related]
7. Role of luteolin in overcoming Parkinson's disease.
Siddique YH
Biofactors; 2021 Mar; 47(2):198-206. PubMed ID: 33443305
[TBL] [Abstract][Full Text] [Related]
8. Luteolin protects rat PC12 and C6 cells against MPP+ induced toxicity via an ERK dependent Keap1-Nrf2-ARE pathway.
Wruck CJ; Claussen M; Fuhrmann G; Römer L; Schulz A; Pufe T; Waetzig V; Peipp M; Herdegen T; Götz ME
J Neural Transm Suppl; 2007; (72):57-67. PubMed ID: 17982879
[TBL] [Abstract][Full Text] [Related]
9. Nuclear Factor Kappa B: A Nobel Therapeutic Target of Flavonoids Against Parkinson's Disease.
Singh NK; Singh A; Mayank
Comb Chem High Throughput Screen; 2024 Jan; ():. PubMed ID: 38243959
[TBL] [Abstract][Full Text] [Related]
10. Luteolin as a potential preventive and therapeutic candidate for Alzheimer's disease.
Kwon Y
Exp Gerontol; 2017 Sep; 95():39-43. PubMed ID: 28528007
[TBL] [Abstract][Full Text] [Related]
11. Protection of Cultured Cortical Neurons by Luteolin against Oxidative Damage through Inhibition of Apoptosis and Induction of Heme Oxygenase-1.
Kim S; Chin YW; Cho J
Biol Pharm Bull; 2017; 40(3):256-265. PubMed ID: 28250268
[TBL] [Abstract][Full Text] [Related]
12. Revisiting luteolin: An updated review on its anticancer potential.
Rauf A; Wilairatana P; Joshi PB; Ahmad Z; Olatunde A; Hafeez N; Hemeg HA; Mubarak MS
Heliyon; 2024 Mar; 10(5):e26701. PubMed ID: 38455556
[TBL] [Abstract][Full Text] [Related]
13. A Comprehensive Review on Therapeutic Potential of Chrysin in Brain Related Disorders.
Goyal A; Singh G; Verma A
CNS Neurol Disord Drug Targets; 2023; 22(6):789-800. PubMed ID: 35657041
[TBL] [Abstract][Full Text] [Related]
14. Luteolin and Apigenin Attenuate 4-Hydroxy-2-Nonenal-Mediated Cell Death through Modulation of UPR, Nrf2-ARE and MAPK Pathways in PC12 Cells.
Wu PS; Yen JH; Kou MC; Wu MJ
PLoS One; 2015; 10(6):e0130599. PubMed ID: 26087007
[TBL] [Abstract][Full Text] [Related]
15. Unveiling Nature's potential: Promising natural compounds in Parkinson's disease management.
Bhusal CK; Uti DE; Mukherjee D; Alqahtani T; Alqahtani S; Bhattacharya A; Akash S
Parkinsonism Relat Disord; 2023 Oct; 115():105799. PubMed ID: 37633805
[TBL] [Abstract][Full Text] [Related]
16. An updated review on the versatile role of chrysin in neurological diseases: Chemistry, pharmacology, and drug delivery approaches.
Talebi M; Talebi M; Farkhondeh T; Kopustinskiene DM; Simal-Gandara J; Bernatoniene J; Samarghandian S
Biomed Pharmacother; 2021 Sep; 141():111906. PubMed ID: 34328092
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic potentials of crocin in medication of neurological disorders.
Ahmed S; Hasan MM; Heydari M; Rauf A; Bawazeer S; Abu-Izneid T; Rebezov M; Shariati MA; Daglia M; Rengasamy KR
Food Chem Toxicol; 2020 Nov; 145():111739. PubMed ID: 32916219
[TBL] [Abstract][Full Text] [Related]
18. Neuroinflammation in Alzheimer's disease and beneficial action of luteolin.
Delgado A; Cholevas C; Theoharides TC
Biofactors; 2021 Mar; 47(2):207-217. PubMed ID: 33615581
[TBL] [Abstract][Full Text] [Related]
19. Luteolin alleviates cognitive impairment in Alzheimer's disease mouse model via inhibiting endoplasmic reticulum stress-dependent neuroinflammation.
Kou JJ; Shi JZ; He YY; Hao JJ; Zhang HY; Luo DM; Song JK; Yan Y; Xie XM; Du GH; Pang XB
Acta Pharmacol Sin; 2022 Apr; 43(4):840-849. PubMed ID: 34267346
[TBL] [Abstract][Full Text] [Related]
20. Antioxidant and Nrf2 inducing activities of luteolin, a flavonoid constituent in Ixeris sonchifolia Hance, provide neuroprotective effects against ischemia-induced cellular injury.
Zhang YC; Gan FF; Shelar SB; Ng KY; Chew EH
Food Chem Toxicol; 2013 Sep; 59():272-80. PubMed ID: 23770353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
